About
Brandon Capital is a Melbourne-based venture capital fund that invests from seed through to growth rounds. Founded by Chris Nave and Stephen Thompson, it focuses on life sciences and biotech, healthtech and consumer tech, and closed its Fund Six at more than $430 million in 2025 with a $150 million commitment from the National Reconstruction Fund Corporation. Recent investments include AdvanCell Isotopes and Lumonus.
